𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness

✍ Scribed by Brouillet, Jean-Paul; Theillet, Charles; Maudelonde, Thierry; Defrenne, Annick; Simony-Lafontaine, Joëlle; Sertour, Jacqueline; Pujol, Henri; Jeanteur, Philippe; Rochefort, Henri

Book ID
123492158
Publisher
Elsevier Science
Year
1990
Weight
696 KB
Volume
26
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

int-2 Amplification in breast cancer: As
int-2 Amplification in breast cancer: Association with decreased survival and relationship to amplification of c-erbb-2 and c-myc
✍ J. A. Henry; C. Hennessy; D. L. Leveit; T. W. J. Len Nard; B. R. Westley; F. E. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 778 KB

Amplification of the int-2 oncogene was measured in a series of breast tumours and related to amplification of the c-myc and c-erbB-2 oncogenes, histopathological features and relapse-free and overall survival. int-2 was amplified in I I%, c-myc in 20% and c-erbB-2 in 27% of the tumours assessed. in

Significance of c-erb5-2 amplification a
Significance of c-erb5-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer
✍ Jeannette Babiak; Judith Hugh; Sibrand Poppema 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 718 KB

Background. Amplification of the c-erbB-2 protooncogene and DNA aneuploidy have been reported to correlate with poor patient prognosis in human breast cancer. Several studies have investigated the prognostic value of these two factors in heterogeneous populations of patients with node-positive and n

The prognostic value of p53 and c-erb b-
The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma : A multivariate analysis of prognostic factors in 613 patients with a follow-up of 14–30 years
✍ Wenche Reed; Einar Hannisdal; Per Johannes Boehler; Stein Gundersen; Herman Host 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

## BACKGROUND. Approximately 30% of breast carcinoma patients with negative lymph nodes die of their disease. Biologic markers such p53 protein and c-erb B-2 have been related to tumor progression, but their prognostic value remains controversial. ## METHODS. Two large series of a total of 613 ly